This compound is a pharmaceutical intermediate featuring a tert-butoxycarbonyl-protected amino group and a hydroxyl group on a cyclohexane ring with defined cis stereochemistry. It is primarily used as a building block in the synthesis of more complex pharmaceutical compounds.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 224309-64-2
CIS-4-(TERT-BUTOXYCARBONYLAMINO)CYCLOHEXANOL
Pharmaceutical intermediate for synthesis
CIS-4-(TERT-BUTOXYCARBONYLAMINO)CYCLOHEXANOL
Pharmaceutical intermediate for API synthesis
Ethyl 4-amino-2,2-difluorobutanoate hydrochloride
pharmaceutical intermediate for API synthesis
4,6-Dichloro-pyridazine-3-carboxylic acid lithium salt monohydrate
pharmaceutical intermediate
3-Pyridazinecarboxylic acid, 6-chloro-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-
Pharmaceutical intermediate for deucravacitinib synthesis
6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic acid
Pharmaceutical intermediate for deucravacitinib
tert-butyl N-(4-hydroxycyclohexyl)carbamate
DQARDWKWPIRJEH-UHFFFAOYSA-N
CC(C)(C)OC(=O)NC1CCC(CC1)O